Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 2
1998 7
1999 5
2000 1
2001 1
2002 5
2003 2
2004 1
2006 2
2008 3
2009 2
2012 2
2013 4
2014 6
2015 2
2016 3
2017 4
2018 9
2019 10
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Kappos L, Bar-Or A, Cree BAC, Fox RJ, Giovannoni G, Gold R, Vermersch P, Arnold DL, Arnould S, Scherz T, Wolf C, Wallström E, Dahlke F; EXPAND Clinical Investigators. Kappos L, et al. Lancet. 2018 Mar 31;391(10127):1263-1273. doi: 10.1016/S0140-6736(18)30475-6. Epub 2018 Mar 23. Lancet. 2018. PMID: 29576505 Clinical Trial.
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S. Dal-Bianco A, et al. Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27. Acta Neuropathol. 2017. PMID: 27796537 Free PMC article.
Peri-ictal ECG changes in childhood epilepsy: implications for detection systems.
Jansen K, Varon C, Van Huffel S, Lagae L. Jansen K, et al. Epilepsy Behav. 2013 Oct;29(1):72-6. doi: 10.1016/j.yebeh.2013.06.030. Epub 2013 Aug 10. Epilepsy Behav. 2013. PMID: 23939031
The algorithm of Leutmezer et al. was used to find the temporal relationship between the change in heart rate and seizure onset. ...
The algorithm of Leutmezer et al. was used to find the temporal relationship between the change in heart rate and seizure onset. ...
Month-of-birth-effect in multiple sclerosis in Austria.
Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F. Walleczek NK, et al. Mult Scler. 2019 Dec;25(14):1870-1877. doi: 10.1177/1352458518810924. Epub 2018 Nov 22. Mult Scler. 2019. PMID: 30463473
Cranial Nerve Enhancement in Multiple Sclerosis Is Associated With Younger Age at Onset and More Severe Disease.
Haider L, Chan WE, Olbert E, Mangesius S, Dal-Bianco A, Leutmezer F, Prayer D, Thurnher M. Haider L, et al. Front Neurol. 2019 Nov 6;10:1085. doi: 10.3389/fneur.2019.01085. eCollection 2019. Front Neurol. 2019. PMID: 31781014 Free PMC article.
Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR). Guger M, et al. J Neurol. 2019 Nov;266(11):2672-2677. doi: 10.1007/s00415-019-09464-0. Epub 2019 Jul 16. J Neurol. 2019. PMID: 31312958
An update on Peginterferon beta-1a Management in Multiple Sclerosis: results from an interdisciplinary Board of German and Austrian Neurologists and dermatologists.
Kolb-Mäurer A, Sunderkötter C, Kukowski B, Meuth SG; members of an expert meeting. Kolb-Mäurer A, et al. BMC Neurol. 2019 Jun 15;19(1):130. doi: 10.1186/s12883-019-1354-y. BMC Neurol. 2019. PMID: 31202258 Free PMC article.
Management of multiple sclerosis patients in central European countries: current needs and potential solutions.
Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Hojs Fabjan T, Horáková D, Illes Z, Klimová E, Leutmezer F, Rejdak K, Rozsa C, Šega Jazbec S, Szilasiová J, Turčáni P, Vachová M, Vécsei L, Havrdová E. Berger T, et al. Ther Adv Neurol Disord. 2018 Feb 22;11:1756286418759189. doi: 10.1177/1756286418759189. eCollection 2018. Ther Adv Neurol Disord. 2018. PMID: 29511382 Free PMC article. Review.
Contemporary treatment options for relapsing-remitting multiple sclerosis.
Salhofer-Polanyi S, Leutmezer F. Salhofer-Polanyi S, et al. Drugs Today (Barc). 2014 May;50(5):365-83. doi: 10.1358/dot.2014.50.5.2132741. Drugs Today (Barc). 2014. PMID: 24918837 Review.
74 results
Jump to page
Feedback